🔴 20/20 Biolabs is trading 5.55% down in pre-market with reconvened shareholder vote scheduled

20/20 Biolabs is trading 5.55% down at $0.45, extending recent declines after falling 8.59% on September 15 and 7.05% on September 14.

• No new company-specific announcement or filing was identified for September 16.
• Investors may be monitoring the reconvened shareholder vote on increasing authorized common shares from 50 million to 500 million, scheduled for 10:00 a.m. Eastern Time.
• A direct causal link between the vote and decline remains unconfirmed.